Vassil Delchev

Dr. Vassil Delchev

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2010 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
VDVassil Delchev
Vassil Delchev
ASAndrzej L. Sobolewski
Andrzej L. Sobolewski
WDWolfgang Domcke
Wolfgang Domcke
We performed a comparative theoretical study of the relaxation mechanisms of the excited states of uracil and 4-pyrimidinone with the CASSCF, CASPT2, and CC2 ab initio methods. The calculated vertical excitation energies agree with the experimental UV absorption maxima of the two compounds. Three low-lying conical intersections between the S0 and S1 states (one for uracil, two for 4-pyrimidinone) are established. They are accessible from the Franck–Condon region of the 1ππ* state through out-of-plane deformations related to CC (for uracil) or CN (for 4-pyrimidinone) torsions of the heterocyclic ring. These conical intersections mediate the radiationless deactivation of the compounds after excitation of the lowest 1ππ* state. The relaxation of the 1ππ* state of 4-pyrimidinone via CC twisting is hindered by a barrier. The relaxed scan of the CN double-bond twisting of 4-pyrimidinone indicates that the formation of the Dewar form may represent a photochemical channel in 4-pyrimidinone. This fact is detrimental for the photostability of 4-pyrimidinone, since the Dewar form is separated by a high potential-energy barrier from the canonical form of 4-pyrimidinone on the ground-state potential-energy surface, which prevents a thermal back-reaction. The investigation of the vertical excitation energies and the reaction paths shows that 4-pyrimidinone is less photostable than uracil.

4 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Stoyanka Atanasova NikolovaStoyanka Atanasova Nikolova
Stoyanka Atanasova Nikolova
Miglena MilushevaMiglena Milusheva
Miglena Milusheva
Vera Nikolaeva GledachevaVera Nikolaeva Gledacheva
Vera Nikolaeva Gledacheva
Mehran Feizi-DehnayebiMehran Feizi-Dehnayebi
Mehran Feizi-Dehnayebi
LKLidia Kaynarova
Lidia Kaynarova
MTMina Todorova
Mina Todorova
Anticoagulants prevent the blood from developing the coagulation process, which is the primary cause of death in thromboembolic illnesses. Phenindione (PID) is a well-known anticoagulant that is rarely employed because it totally prevents coagulation, which can be a life-threatening complication. The goal of the current study is to synthesize drug-loaded Ag NPs to slow down the coagulation process. Methods: A rapid synthesis and stabilization of silver nanoparticles as drug-delivery systems for phenindione (PID) were applied for the first time. Results: Several methods are used to determine the size of the resulting Ag NPs. Additionally, the drug-release capabilities of Ag NPs were established. Density functional theory (DFT) calculations were performed for the first time to indicate the nature of the interaction between PID and nanostructures. DFT findings supported that galactose-loaded nanostructure could be a proper delivery system for phenindione. The drug-loaded Ag NPs were characterized in vitro for their antimicrobial, cytotoxic, and anticoagulant activities, and ex vivo for spasmolytic activity. The obtained data confirmed the drug-release experiments. Drug-loaded Ag NPs showed that prothrombin time (PT, sec) and activated partial thromboplastin time (APTT, sec) are approximately 1.5 times longer than the normal values, while PID itself stopped coagulation at all. This can make the PID-loaded Ag NPs better therapeutic anticoagulants. PID was compared to PID-loaded Ag NPs in antimicrobial, spasmolytic activity, and cytotoxicity. All the experiments confirmed the drug-release results.

15 March 2001 in Monatshefte für Chemie - Chemical Monthly
Verified
Journal Article
Closed access
PDF file
VDVassil Delchev
Vassil Delchev
HMHans Mikosch
Hans Mikosch
GNGeorgi St. Nikolov
Georgi St. Nikolov

30 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMina Todorova
Mina Todorova
Miglena MilushevaMiglena Milusheva
Miglena Milusheva
LKLidia Kaynarova
Lidia Kaynarova
DGDeana Georgieva
Deana Georgieva
VDVassil Delchev
Vassil Delchev
Stoyanka Atanasova NikolovaStoyanka Atanasova Nikolova
Stoyanka Atanasova Nikolova
Chronic, multifactorial illnesses of the gastrointestinal tract include inflammatory bowel diseases. One of the greatest methods for regulated medicine administration in a particular region of inflammation is the nanoparticle system. Silver nanoparticles (Ag NPs) have been utilized as drug delivery systems in the pharmaceutical industry. The goal of the current study is to synthesize drug-loaded Ag NPs using a previously described 3-methyl-1-phenylbutan-2-amine, as a mebeverine precursor (MP). Methods: A green, galactose-assisted method for the rapid synthesis and stabilization of Ag NPs as a drug-delivery system is presented. Galactose was used as a reducing and capping agent forming a thin layer encasing the nanoparticles. Results: The structure, size distribution, zeta potential, surface charge, and the role of the capping agent of drug-loaded Ag NPs were discussed. The drug release of the MP-loaded Ag NPs was also investigated. The Ag NPs indicated a very good drug release between 80 and 85%. Based on the preliminary results, Ag NPs might be a promising medication delivery system for MP and a useful treatment option for inflammatory bowel disease. Therefore, future research into the potential medical applications of the produced Ag NPs is necessary.

10 July 2012 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
RBRumyana I. Bakalska
Rumyana I. Bakalska
VDVassil Delchev
Vassil Delchev

1 July 2004 in Journal of Structural Chemistry
Verified
Journal Article
Closed access
PDF file
VDVassil Delchev
Vassil Delchev